The United States Patent and Trademark Office (USPTO) has granted U.S. patent 12,122,741, which claims the composition of matter of lead preclinical candidates in Cybin Inc’s (NYSE:CYBN) CYB005 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback